LBRX ▲ +0.1% - LB Pharmaceuticals Inc
$LBRX - LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer
LB Pharmaceuticals appointed Susan G. Kozauer, M.D. as Chief Medical Officer, a leadership addition the market received positively as the stock rose 0.1% today. The appointment of an experienced CMO typically signals strengthened clinical and regulatory capabilities for a biotech company.
15-SEP-2026 08:00 AM ET
Share this post
More filings for $LBRX
LBRX ▼ -4.0% - LB Pharmaceuticals IncSep 3, 2026LBRX - LB Pharmaceuticals Inc - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026$LBRX SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026$LBRX SEC Filing Update (16-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 16, 2026
View full $LBRX filing history →💬 Comments
Loading comments…
Leave a comment
